Taiwan concedes to US industry on GMP (good manufacturing practice) requirements but European companies still at a disadvantage
This article was originally published in Clinica
Taiwan's Department of Health has reached an agreement with the US Health Industry Manufacturers Association (HIMA) that will allow US medical device companies to demonstrate compliance with Taiwan's planned good manufacturing practice (GMP) requirements without submitting a complete plant master file.
You may also be interested in...
CEO breaks down to Scrip how the Hong Kong-based company managed its way through the coronavirus outbreak in China, saying improvisation was critical.
GNC announces "significant" store and management staff furloughs and other cost-cutting moves "to protect the long-term prospects for the business." Vitamin Shoppe told customers that its stores remain open though it reduced business hours.
California-based biosensor patch company LifeSignals Group plans to file for an emergency use authorization from the US FDA for a new patch that can monitor vital signs to help individuals decide when to seek the help of a health care provider. See what LifeSignals’ CEO Surendar Magar said about it here.